pone.0279821.s001.tif (1.28 MB)
Models established across different cancer type from PDXs models as either PDXO cultures in vitro or for 3D ex vivo assays.
figure
posted on 2023-01-05, 18:41 authored by Xiaoxi Xu, Rajendra Kumari, Jun Zhou, Jing Chen, Binchen Mao, Jingjing Wang, Meiling Zheng, Xiaolong Tu, Xiaoyu An, Xiaobo Chen, Likun Zhang, Xiaoli Tian, Haojie Wang, Xin Dong, Zhengzheng Bao, Sheng Guo, Xuesong Ouyang, Limei Shang, Fei Wang, Xuefei Yan, Rui Zhang, Robert G. J. Vries, Hans Clevers, Qi-Xiang LiFor PDXO collections, the % success rate per cancer type was determined based on the number of models successfully biobanked versus the number of models that failed organoid establishment. In comparison the dissociated PDX in 3D ex vivo conditions could not be maintained in continuous culture nor cryopreserved and resuscitated, therefore hindering the generation of a living biobank. PDX ex vivo cultures were approximately 25–35% successful.
(TIF)
History
Usage metrics
Categories
Keywords
cancer stem cellspdx )/ organoidexisting pdx librarypdo ), drivenderived tumor xenograftimmune cell codiv >< pconfirmed high degree550 matched pairsmatched pairscarcinoma pdxcsc ),derived xenograftsvivo used extensivelytranslational oncologythroughput screeningsurrogate subjectspredictive modelspatients amenablelead compoundsinterchangeability ”including populationhts ).engineering enables
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC